87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting
SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics hereafter) announced that two major clinical updates...
United States Data Monitoring Committee European Medicines Agency Connective Tissue Oncology Society Annual Meeting Prnewswire Abbisko Therapeutics Co Ltd Tissue Oncology Society Annual Meeting
Source: businessinsider.com